These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Targeting cellular metabolism to reduce head and neck cancer growth. Yang J; Guo Y; Seo W; Zhang R; Lu C; Wang Y; Luo L; Paul B; Yan W; Saxena D; Li X Sci Rep; 2019 Mar; 9(1):4995. PubMed ID: 30899051 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism. Huang Q; Stalnecker C; Zhang C; McDermott LA; Iyer P; O'Neill J; Reimer S; Cerione RA; Katt WP J Biol Chem; 2018 Mar; 293(10):3535-3545. PubMed ID: 29317493 [TBL] [Abstract][Full Text] [Related]
8. Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC. Lee JS; Kang JH; Lee SH; Hong D; Son J; Hong KM; Song J; Kim SY Cell Death Dis; 2016 Dec; 7(12):e2511. PubMed ID: 27929535 [TBL] [Abstract][Full Text] [Related]
9. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy. Masamha CP; LaFontaine P J Cell Biochem; 2018 Jul; 119(7):6136-6145. PubMed ID: 29633308 [TBL] [Abstract][Full Text] [Related]
11. GLS1 depletion inhibited colorectal cancer proliferation and migration via redox/Nrf2/autophagy-dependent pathway. Liu HY; Zhang HS; Liu MY; Li HM; Wang XY; Wang M Arch Biochem Biophys; 2021 Sep; 708():108964. PubMed ID: 34119480 [TBL] [Abstract][Full Text] [Related]
12. Analysis of anti-tumor effect and mechanism of GLS1 inhibitor CB-839 in colorectal cancer using a stroma-abundant tumor model. Miyamoto R; Takigawa H; Yuge R; Shimizu D; Ariyoshi M; Otani R; Tsuboi A; Tanaka H; Yamashita K; Hiyama Y; Urabe Y; Ishikawa A; Sentani K; Oka S Exp Mol Pathol; 2024 Jun; 137():104896. PubMed ID: 38703552 [TBL] [Abstract][Full Text] [Related]
13. Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis. Kono M; Yoshida N; Maeda K; Suárez-Fueyo A; Kyttaris VC; Tsokos GC Arthritis Rheumatol; 2019 Nov; 71(11):1869-1878. PubMed ID: 31233276 [TBL] [Abstract][Full Text] [Related]
14. Targeting GLS1 to cancer therapy through glutamine metabolism. Yu W; Yang X; Zhang Q; Sun L; Yuan S; Xin Y Clin Transl Oncol; 2021 Nov; 23(11):2253-2268. PubMed ID: 34023970 [TBL] [Abstract][Full Text] [Related]
15. [Exploration of mechanism of total triterpenoids from fruits of Chaenomeles speciosa against senescent GES-1 cells induced by D-galactose based on Gln/GLS1/α-KG metabolic axis and mitochondrial apoptosis signaling pathway]. He JY; Yang JX; Qin SY; Zheng JQ; Guo YR; Ma TX Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(8):2230-2246. PubMed ID: 38812238 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a novel glutaminase inhibitor. Cederkvist H; Kolan SS; Wik JA; Sener Z; Skålhegg BS FEBS Open Bio; 2022 Jan; 12(1):163-174. PubMed ID: 34698439 [TBL] [Abstract][Full Text] [Related]
17. Glutaminolysis Promotes Collagen Translation and Stability via α-Ketoglutarate-mediated mTOR Activation and Proline Hydroxylation. Ge J; Cui H; Xie N; Banerjee S; Guo S; Dubey S; Barnes S; Liu G Am J Respir Cell Mol Biol; 2018 Mar; 58(3):378-390. PubMed ID: 29019707 [TBL] [Abstract][Full Text] [Related]
18. Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer. Pan T; Gao L; Wu G; Shen G; Xie S; Wen H; Yang J; Zhou Y; Tu Z; Qian W Biochem Biophys Res Commun; 2015 Jan; 456(1):452-8. PubMed ID: 25482439 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Glutaminase 1 Attenuates Experimental Pulmonary Fibrosis. Cui H; Xie N; Jiang D; Banerjee S; Ge J; Sanders YY; Liu G Am J Respir Cell Mol Biol; 2019 Oct; 61(4):492-500. PubMed ID: 30943369 [TBL] [Abstract][Full Text] [Related]